Revelation Biosciences Inc (REVB NASDAQ) stock market data APIs
$1.2468
-0.02(-1.6%)
as of March 13, 2026
Try our APIs with
free plan!
Revelation Biosciences Inc Financial Data Overview
Price chart is built with
Anychart
Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Prev. Close
1.2468
Open
1.2265
High
1.2758
Low
1.2034
52 wk Range
1.19-44.772
Market Cap
4 670 K
Shares Outstanding
3 720 K
EPS
-1.65
Beta
-0.134
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Revelation Biosciences Inc data using free add-ons & libraries
Get Revelation Biosciences Inc Fundamental Data
Revelation Biosciences Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -9 043 756
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-27
- EPS/Forecast: -3.66
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Revelation Biosciences Inc News
New
Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026
SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 26, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2026, the Company will imp...
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Intel Corp. 100,356,754 48.13 4...
Revelation Bio To Share New Data From PRIME Study Of Gemini In March
(RTTNews) - Revelation Biosciences Inc. (REVB) is preparing to showcase new clinical data that could mark an important step forward in the treatment of kidney disease. The company announced that findi...
Revelation Biosciences files to sell 13.07M shares of common stock by selling shareholders
* Revelation Biosciences (NASDAQ:REVB [https://seekingalpha.com/symbol/REVB]) filed to sell 13.07 million common stock. * This prospectus is not an offer to sell these securities. * The company...
Get Revelation Biosciences Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
